R.S. Bhangoo
Papers
1
Total Citations
26
H-Index
1
About
Dr. R.S. Bhangoo is a leading radiation oncologist whose research centers on advancing proton therapy for gastrointestinal and liver cancers. His most impactful contribution is pioneering the clinical application of intensity modulated proton therapy (IMPT) for hepatocellular carcinoma (HCC), a notoriously difficult-to-treat malignancy. In his landmark 2021 study, "Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience" (26 citations), Dr. Bhangoo demonstrated that IMPT can deliver highly conformal radiation doses to liver tumors while significantly sparing surrounding healthy liver tissue and critical organs. This work established a new standard for safely treating HCC with curative intent, particularly in patients with compromised liver function who are poor candidates for surgery. Beyond this foundational study, Dr. Bhangoo’s broader research portfolio explores optimizing proton beam dosimetry and reducing treatment-related toxicities in hepatobiliary cancers. His clinical expertise and rigorous outcomes data have helped position proton therapy as a vital tool in the multidisciplinary management of liver cancer, directly improving patient quality of life and survival.
Research Focus
Key Achievements
Top Papers
- 1